Cross-institution positioning
Apr 30, 2026Reduction leaning. 2 reducing, 1 exited across 3 comparable institutions.
Source: Schedule 13 researchPrestige Consumer Healthcare Inc.
Latest stored close $48.23 as of Oct 9, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Reduction leaning. 2 reducing, 1 exited across 3 comparable institutions.
Source: Schedule 13 research2 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsRecent Forms 3/4/5 activity is available, with no non-amendment non-derivative SEC-coded P/S transactions in the rolling 90-day window. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/53 non-amendment material events in the last 90 days; 1 capital-related filing/event (0 equity-related, 1 debt-related); Latest classified evidence: Director or executive change. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +6.5% YoY; Net income -38.5% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 14% through its reported 52-week range; -25.9% over one year.
Source: Stored historical price seriesFiled Apr 30, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Aug 4, 2026 | ZIER DAWN M. | AGrant, award, or other acquisition | Common Stock, par value $0.01 per share | 3.0K | $0.00 | Direct | Aug 5, 2026 |
| Aug 4, 2026 | Kelly John F. | AGrant, award, or other acquisition | Common Stock, par value $0.01 per share | 3.0K | $0.00 | Direct | Aug 5, 2026 |
| Aug 4, 2026 | DArecca James | AGrant, award, or other acquisition | Common Stock, par value $0.01 per share | 3.0K | $0.00 | Direct | Aug 5, 2026 |
| Aug 4, 2026 | Clark Celeste A. | AGrant, award, or other acquisition | Common Stock, par value $0.01 per share | 3.0K | $0.00 | Direct | Aug 5, 2026 |
| Aug 4, 2026 | BYOM JOHN E | AGrant, award, or other acquisition | Common Stock, par value $0.01 per share | 3.0K | $0.00 | Direct | Aug 5, 2026 |
| May 11, 2026 | Zerillo Jeffrey | SOpen-market or private sale | Common Stock, par value $0.01 per share | 351 | $52.28 | Direct | May 12, 2026 |
| May 7, 2026 | Zerillo Jeffrey | SOpen-market or private sale | Common Stock, par value $0.01 per share | 305 | $54.36 | Direct | May 11, 2026 |
| May 7, 2026 | Zerillo Jeffrey | FTax/price withholding or payment | Common Stock, par value $0.01 per share | 351 | $54.59 | Direct | May 11, 2026 |
| May 7, 2026 | Sacco Christine | FTax/price withholding or payment | Common Stock, par value $0.01 per share | 991 | $54.59 | Direct | May 11, 2026 |
| May 7, 2026 | Lombardi Ronald M. | FTax/price withholding or payment | Common Stock, par value $0.01 per share | 2.5K | $54.59 | Direct | May 11, 2026 |
| May 7, 2026 | Mekhail Adel | FTax/price withholding or payment | Common Stock, par value $0.01 per share | 487 | $54.59 | Direct | May 11, 2026 |
| May 5, 2026 | Zerillo Jeffrey | SOpen-market or private sale | Common Stock, par value $0.01 per share | 1.2K | $54.99 | Direct | May 7, 2026 |
| May 5, 2026 | Zerillo Jeffrey | FTax/price withholding or payment | Common Stock, par value $0.01 per share | 307 | $55.75 | Direct | May 7, 2026 |
| May 5, 2026 | Sacco Christine | FTax/price withholding or payment | Common Stock, par value $0.01 per share | 1.3K | $55.75 | Direct | May 7, 2026 |
| May 5, 2026 | Lombardi Ronald M. | FTax/price withholding or payment | Common Stock, par value $0.01 per share | 2.2K | $55.75 | Direct | May 7, 2026 |
| May 5, 2026 | Zerillo Jeffrey | SOpen-market or private sale | Common Stock, par value $0.01 per share | 346 | $55.32 | Direct | May 6, 2026 |
| May 4, 2026 | Sacco Christine | AGrant, award, or other acquisition | Common Stock, par value $0.01 per share | 12.0K | $0.00 | Direct | May 6, 2026 |
| May 4, 2026 | Sacco Christine | FTax/price withholding or payment | Common Stock, par value $0.01 per share | 3.4K | $55.31 | Direct | May 6, 2026 |
| May 4, 2026 | Sacco Christine | AGrant, award, or other acquisition | Common Stock, par value $0.01 per share | 7.0K | $0.00 | Direct | May 6, 2026 |
| May 4, 2026 | P'Pool William | AGrant, award, or other acquisition | Common Stock, par value $0.01 per share | 4.2K | $0.00 | Direct | May 6, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | 8-K | 5.02 | Director or executive change | — | Filing |
| Aug 6, 2026 | 8-K | 2.02, 7.01, 9.01 | Results of operations / financial condition; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Jul 15, 2026 | 8-K | 1.01, 2.03, 9.01 | Material definitive agreement; New direct financial obligation; Financial statements / exhibits | Debt | Filing |
| Jul 9, 2026 | 8-K/AAmendment | 9.01 | Financial statements / exhibits | — | Filing |
| Jul 6, 2026 | 8-K | 1.01, 2.03, 7.01, 9.01 | Material definitive agreement; New direct financial obligation; Regulation FD disclosure; Financial statements / exhibits | Debt | Filing |
| Jun 30, 2026 | 8-K/AAmendment | 9.01 | Financial statements / exhibits | — | Filing |
| Jun 16, 2026 | 8-K | 1.01, 2.01, 2.03, 8.01, 9.01 | Material definitive agreement; Acquisition or disposition of assets; New direct financial obligation; Other event; Financial statements / exhibits | Debt | Filing |
| May 13, 2026 | 8-K | 1.01, 2.02, 7.01, 9.01 | Material definitive agreement; Results of operations / financial condition; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Mar 20, 2026 | 8-K | 1.01, 7.01, 8.01, 9.01 | Material definitive agreement; Regulation FD disclosure; Other event; Financial statements / exhibits | — | Filing |
| Feb 5, 2026 | 8-K | 2.02, 7.01, 9.01 | Results of operations / financial condition; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Nov 6, 2025 | 8-K | 2.02, 7.01, 9.01 | Results of operations / financial condition; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 30, 2026 | $265.7M | +6.5% |
| Ended Dec 31, 2025 | $283.4M | -2.4% |
| Ended Sep 30, 2025 | $274.1M | -3.4% |
| Ended Jun 30, 2025 | $249.5M | -6.6% |
| Period | Revenue | YoY |
|---|---|---|
| Ended Mar 31, 2026 | $1.1B | -4.3% |
| Ended Mar 31, 2025 | $1.1B | +1.1% |
| Ended Mar 31, 2024 | $1.1B | -0.2% |
| Ended Mar 31, 2023 | $1.1B | +3.8% |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Capital Management CIK0002100119 | Jun 30, 2026 quarter end Aug 13, 2026 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 2.1M | $48.23 | |||
| Vanguard Capital Management CIK0002100119 | Mar 31, 2026 observed Apr 30, 2026 filed · 30d Initial Schedule 13G | Initial Schedule 13G | 2.5M | 12.00% | $59.27 | $56.32 | $48.23 |
| Vanguard Group CIK0000102909 | Mar 13, 2026 observed Mar 27, 2026 filed · 14d Schedule 13G amendment | Exit below reporting threshold | 0 -5.8M | 0.00% -11.60 pts | $61.45 | $59.22 | $48.23 |
Compare PBH with other securities showing similar institutional activity or recent accumulation across several tracked institutions.